LOG IN

Members and suppliers: Join our online community

Access our full library of resources, register for events and webinars and share audits and other assessments

News

Sort By
This event was published 22 hours ago
Energize Program Overview

Energize Program Overview

External | 11–12 Feb 2026

The Energize program aims to increase access to renewable electricity for suppliers in the pharmaceutical industry. The program is growing and now has 26 global pharmaceutical companies working to support their suppliers to decarbonize and mitigate the overall environmental impact of the industry. Join Schneider Electric, Energize program manager, to learn more about the program and benefits of participating.

Agenda
What is Energize?
Why is Energize important?
Program Education
Renewable Electricity Procurement Support
Program Benefits
What to expect when you join the program and next steps

Choose your session
Wednesday 11 February
Thursday 12 February

About Energize
The Energize program is a supply chain renewables initiative designed and delivered by Schneider Electric Sustainability Business and endorsed by the PSCI.

Current Energize sponsors: Almirall, Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Charles River Laboratories, Chiesi Group, GSK, Haleon, Johnson & Johnson, Kenvue, Merck (known as MSD outside the United States and Canada), Merck KGaA, Darmstadt, Germany, Novartis, Novo Nordisk, Pfizer, Roche, Sandoz, Sanofi, Schott, Takeda, Teva, UHG, and UCB.

Type
External
Date
11–12 Feb 2026
Language
English
This resource was published on 20 January

PSCI Supplier Newsletter January 2026

Get a quick update on the latest PSCI news. From the newly announced 2026 Board to the launch of the integrated online audit process, new learning courses, upcoming webinars, and more.

This bulletin was published on 16 January

PSCI Extends Appreciation to the 2025 & outgoing Committee and Topic Team Leads

PSCI Extends Appreciation to the 2025 & outgoing Committee and Topic Team Leads

The PSCI extends our sincere gratitude to the Committee and Topic Team Leads for their outstanding contributions throughout 2025. We would like to thank the following Members whose leadership terms ended in 2025.

Sarah Turiano, Capability Committee.
Sarah has led the PSCI’s efforts on training and development for the last three years as Co-Chair of the Capability Committee. She played a pivotal role in shaping the PSCI’s approach to learning and development and oversaw the launch of the Learnster platform.

Enric Bosch, Projects Committee.
Enric helped set up the Projects Committee and act as its first Co-Lead. He established the processes and procedures for investments, ensuring good governance and oversight; while his focus on value and quality led to the endorsement of multiple projects aimed to create deep impact for suppliers.

Vicki Stone-Bjarup, Projects Committee. Following on from her tenure as PSCI Chair, Vicki supported the establishment of the Projects Committee and steered it through its first years as a new venture for the PSCI. Her leadership and enthusiasm for supporting high impact projects ensured achievement of the Committee’s aims.

We would also like to congratulate Vincent Mignone, Environment Topic Team Co-Lead, and Li Liu, China Regional Team Co-Lead, as they transition to the PSCI Board.

Committee Leads:

Birgit Skuballa (Bayer) - Audit

Dorota Wiacek-Trojanowska (Roche) - Audit

Sarah Turiano (Viatris) - Capability

Wenjia Xu (Merck & Co) - Capability

Enric Bosch (Boehringer Ingelheim) - Projects

Vicki Stone-Bjarup (Novo Nordisk) - Projects

Topic Team Leads:

Pietro Butti (Roche) - Management Systems

Bridget Ferrari (Takeda) - Decarbonization

Devin Carsdale (Bristol Myers Squibb) - Decarbonization

Andrea Fasano (Pfizer) - Environment

Vincent Mignone (Kevenue) - Environment

Pamela Cornes (Johnson & Johnson) - Human Rights

Tanya Murphy (AstraZeneca) - Human Rights

Matthew Thomas (AstraZeneca) - Industrial Hygiene

Sarah Jones (Pfizer) - Industrial Hygiene

Dr JVN Reddy (Aurobindo) – PIE & AMR

Reinhold Maeck (Boehringer Ingelheim) - PIE & AMR

Vijaya Kumar Bendi (Johnson & Johnson) - Process Safety

Germano D'Arasmo (Gilead) – Safety

Regional Team Leads:

China: Gary Lu (AstraZeneca) and Li Liu (Boehringer Ingelheim)

India: Aditya Shirodkar (Abbott) and Rohit Virmani (GSK)

This bulletin was published on 15 January

The PSCI Welcomes its 2026 Board of Directors

The Pharmaceutical Supply Chain Initiative is delighted to announce its 2026 leadership appointments and extend heartfelt thanks to outgoing Chair Rob Williams for his impactful contributions, as he moves into the Past Chair role.

Lucy Latham: Chair

Lucy Latham, Global Procurement Head of ESG at Sandoz, will take on the role of Chair of the PSCI Board. Lucy brings over 15 years of expertise in procurement, sustainability, and compliance, with notable roles at Roche, GSK, Thales, and Rolls-Royce. Within the PSCI, Lucy spent 2025 as Vice Chair and was previously co-lead of the Decarbonization Topic Team.

Peter Nestor: Vice Chair

Peter Nestor, Head of Human Rights at Novartis, has been appointed Vice Chair. Within the PSCI, Peter has been active as the past Co-Lead of the Human Rights Topic Team, and now leads the Training Sub-team, building Member capability in this critical area. He is also active on Human Rights projects, including shared engagement with rightsholders and stakeholders and grievance mechanisms.

Daniel Rehm: Treasurer

Daniel Rehm, Operations Manager EEM Global API at Elanco Animal Health Inc., continues his role as Treasurer. Daniel has over 26 years of experience in process development, Health, Safety and Environment, and manufacturing. Daniel has been a dedicated PSCI member since 2016, leading the Process Safety Management Topic Team and co-leading the Capability Committee.

Li Liu: Treasurer

Li Liu, EHS Manager and Global Lead Auditor at Boehringer Ingelheim, will take on the role of PSCI Board Treasurer alongside 2025-2027 Treasurer Daniel Rehm. With 19 years of experience across R&D, operations, and EHS management, Li brings deep expertise in regulatory compliance, auditing, and sustainability. Li has been an active contributor to the PSCI in China for over a decade, serving as Co-lead of the China Regional Team.

Vincent Mignone: Secretary

Vincent Mignone, Senior Manager and EHS professional at Kenvue, has been appointed Secretary. Vincent brings deep expertise in environmental remediation, product stewardship, and sustainability, and is known for his pragmatic approach and commitment to continuous learning. He champions Kenvue’s engagement with the PSCI and was previously Co-Lead of the Environment Topic Team.

Warren Bird: Secretary

Warren Bird, Associate Director in Due Diligence & External Manufacturing at Merck (MSD), joins the Board for a two-year term as Secretary, succeeding James Lee who departed Moderna mid-term. At Merck (MSD), Warren leads EHS assessments of suppliers and supports due diligence and product development to ensure compliance with Merck’s Business Partner Code of Conduct, which aligns with the PSCI Principles.

The PSCI congratulates Lucy, Peter, Daniel, Li, Vincent, and Warren on their roles and looks forward to continued progress under their leadership.

Thank you to outgoing Board Members

We would also like to extend our heartfelt thanks to outgoing Board Members for their service:

Deirdre O'Reilly completed her term as Past Chair, leaving behind a lasting legacy including establishing both the Supplier Partnership program and the Projects Committee.

Ranjana Ganguly, departing Treasurer, was instrumental in ensuring PSCI’s financial sustainability and driving the PSCI’s presence and activities in India.

Rincy Joseph, departing Secretary, provided clarity and direction to PSCI’s governance, and led strategic initiatives such as the forthcoming upgrade of the PSCI’s digital platform.

Thank You Rob Williams

As Rob Williams transitions to Past Chair, we extend our sincere gratitude for his impactful leadership and dedication. During his tenure as Chair, Rob achieved key impacts including:

  1. Advancing the PSCI’s approach to collaboration, establishing new partnerships with the Sustainable Markets Initiative and MyGreenLabs.
  2. Building the PSCI’s external profile through engagements with CDMO Live and CPHI.
  3. Taking the Member Meeting to China for the first time, hosted at AstraZeneca.

Thank you, Rob, for your remarkable service and leadership. We look forward to your continued contributions as Past Chair.

This resource was published on 7 January

Webinar: PSCIの紹介、AMRの脅威と製薬企業の責任 PSCI Intro, the Threat of AMR and Pharmaceutical Responsibility

Webinar Video

About: This webinar is presented in Japanese.
Antimicrobial Resistance (AMR) is a critical global challenge that poses serious threats to healthcare systems worldwide. This webinar provides a clear overview of the fundamentals of AMR and outline how the pharmaceutical industry should respond to this pressing issue.
It introduces the Antibiotic Manufacturing Standard developed by the AMR Industry Alliance and highlight emerging certification schemes designed to ensure responsible practices across the industry. In addition, key initiatives led by the SHIONOGI Group will be presented, illustrating the path toward sustainable healthcare.
This session offers a valuable opportunity to deepen your understanding of AMR and explore practical approaches to addressing this global concern.

Speakers

  • Kozo Ohashi, EHS Management Group Member, Corporate Governance Department, Shionogi
    Kozo Ohashi has 3 years of experience in EHS management at SHIONOGI, leading responsible manufacturing initiatives for antimicrobial resistance (AMR). He is a member of the AMR Industry Alliance Manufacturing Working Group and previously spent 18 years in clinical development, contributing to new drug research, including antibiotics.
  • Wenjia Xu, Associate Director, Global Safety and Environment, MSD, PSCI capability committee co-lead
    Wenjia is an EHS professional with 20 years of experience in chemical and pharmaceutical industries, currently at MSD Global Safety and Environment. He specializes in EHS due diligence for suppliers and projects and has strong expertise in PSCI principles through 8 years of audit and capability-building work.

The slides used in the webinar can be accessed here.

This bulletin was published on 24 December 2025

PSCI INDIA SUPPLIER CONFERENCE 2025 - RESOURCES NOW LIVE!

The complete resources for the PSCI INDIA SUPPLIER CONFERENCE 2025 are now available for you to explore.

Open more info to view the resources for Day 1, Day 2 & Day 3.

More Info…
This resource was published on 22 December 2025

A fully online audit approach: What this means for auditors

Document

Please review this document to understand the new fully integrated online audit process.

Launching on the new platform from Monday 2 March.

Join the training sessions on Wednesday 18 February:

10:00 - 11:30 CET
16:00 - 17:30 CET

This resource was published on 22 December 2025

A fully online audit approach: What this means for suppliers

Document

Please review this document to understand the new fully integrated online audit process.

Launching on the new platform from Monday 2 March.

Join the training sessions on Friday 20 February:

10:00 - 11:30 CET
16:00 - 17:30 CET

This resource was published on 19 December 2025

2025: A Year of Impact - Reflections from Rob Williams, PSCI Chair

Video

2025 was another year of impact for the PSCI, full of highlights that were made possible by the dedication and expertise of our Members and delivered benefits for Members, suppliers, and ultimately patients across the world.

From projects to partnerships and beyond, the PSCI is the place to be for collaboration across the sector, creating change, impact, and value.

Through the contributions of the Board, Committees, Topic Teams, and Regional Teams, we are shaping the supplier market and delivering our mission of building responsible supply chains.

Watch this video to hear more.

This event was published on 18 December 2025
PSCI Webinar: PPCP Concentrations in Municipal Sludge & Biosolids, and Antibiotics Risk Analysis

PSCI Webinar: PPCP Concentrations in Municipal Sludge & Biosolids, and Antibiotics Risk Analysis

Webinar | 22 Jan 2026 16:00–17:00 Amsterdam

This webinar presents findings from a North American surveillance study quantifying pharmaceuticals and personal care products (PPCPs) in municipal sludge and biosolids collected from 27 wastewater treatment plants. The session will also demonstrate application of the PSCI team’s Sludge Application Tool to evaluate potential risks associated with land application, with a particular focus on commonly detected antibiotics

Speakers

  • Shubhashini Oza, PhD, PE, is a Process Engineer in Brown and Caldwell’s Research & Innovation group. She leads applied research projects spanning reuse, wastewater, and biosolids. She earned her Ph.D. in Environmental Systems from the University of North Carolina at Charlotte and currently serves as Vice‑Chair for the AWWA Membrane Committee and Treasurer for the State of South Carolina’s Reuse Chapter.
  • Randall Watts, PhD, is a wastewater engineer with nearly 30 years of experience in pharmaceutical and industrial wastewater process engineering. At Brown and Caldwell, he leads projects ranging from treatment plant upgrades to pharmaceuticals‑in‑the‑environment risk assessments and technical support for pharmaceutical clients. Prior to this, he spent most of his career supporting Merck’s global manufacturing sites and corporate EHS teams on regulatory compliance and sustainability initiatives.

What to Expect

  • See real‑world PPCP occurrence data across multiple WWTPs and biosolids matrices.
  • Learn how to run a screening‑level land‑application risk assessment using the PSCI Sludge Application Tool.
  • Understand practical implications for utilities, regulators, and pharmaceutical value‑chain stakeholders.
Type
Webinar
Date
22 Jan 2026 16:00–17:00 Amsterdam
Language
English
This event is in the past
  • Pharmaceuticals In The Environment
  • Anti-Microbial Resistance